Clinical Study Results
Research Sponsor: AstraZeneca
Drug Studied: Saxagliptin and dapagliflozin
Study Title: A study to find out how dapagliflozin, saxagliptin, and metformin
work together to affect blood sugar levels in participants with
type 2 diabetes compared to glimepiride and metformin
Thank you!
Thank you for taking part in the clinical study for the study drugs saxagliptin,
dapagliflozin, glimepiride, and metformin. You and all of the participants helped
researchers learn more about dapagliflozin, saxagliptin, and metformin compared
to glimepiride and metformin to help people with type 2 diabetes. Type 2 diabetes
is also called T2DM.
AstraZeneca sponsored this study and thinks it is important to share the results of
the study with you and the public. An independent non-profit organization called
CISCRP helped prepare this summary of the study results for you. We hope it
helps you understand and feel proud of your important role in medical research.
If you participated in the study and have questions about the results, please speak
with the doctor or staff at your study site.
1